- Home
- AQST vs ODP Comparison
AQST vs ODP Comparison
Compare AQST & ODP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- ODP
- Stock Information
- Founded
- AQST 2004
- ODP 1986
- Country
- AQST United States
- ODP United States
- Employees
- AQST N/A
- ODP N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- ODP Other Specialty Stores
- Sector
- AQST Health Care
- ODP Consumer Discretionary
- Exchange
- AQST Nasdaq
- ODP Nasdaq
- Market Cap
- AQST 809.3M
- ODP 834.9M
- IPO Year
- AQST 2018
- ODP N/A
- Fundamental
- Price
- AQST $6.99
- ODP $27.78
- Analyst Decision
- AQST Strong Buy
- ODP Hold
- Analyst Count
- AQST 7
- ODP 1
- Target Price
- AQST $10.71
- ODP $19.00
- AVG Volume (30 Days)
- AQST 3.6M
- ODP 1.1M
- Earning Date
- AQST 10-31-2025
- ODP 11-05-2025
- Dividend Yield
- AQST N/A
- ODP N/A
- EPS Growth
- AQST N/A
- ODP N/A
- EPS
- AQST N/A
- ODP 0.84
- Revenue
- AQST $44,132,000.00
- ODP $6,690,000,000.00
- Revenue This Year
- AQST N/A
- ODP N/A
- Revenue Next Year
- AQST $51.50
- ODP N/A
- P/E Ratio
- AQST N/A
- ODP $33.13
- Revenue Growth
- AQST N/A
- ODP N/A
- 52 Week Low
- AQST $2.12
- ODP $11.85
- 52 Week High
- AQST $7.55
- ODP $32.21
- Technical
- Relative Strength Index (RSI)
- AQST 63.34
- ODP 69.00
- Support Level
- AQST $6.78
- ODP $27.69
- Resistance Level
- AQST $7.55
- ODP $27.97
- Average True Range (ATR)
- AQST 0.41
- ODP 0.12
- MACD
- AQST 0.04
- ODP -0.27
- Stochastic Oscillator
- AQST 71.13
- ODP 41.06
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About ODP The ODP Corporation
The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on international operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue stems from the Veyer division.